| Primary |
| Acute Lymphocytic Leukaemia |
14.0% |
| Acute Myeloid Leukaemia |
10.8% |
| Rheumatoid Arthritis |
8.6% |
| Drug Use For Unknown Indication |
7.5% |
| Ill-defined Disorder |
7.5% |
| Haemorrhoids |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Prophylaxis |
5.4% |
| Dermatitis Atopic |
4.3% |
| Thyrotoxic Crisis |
4.3% |
| Adrenal Disorder |
3.2% |
| Cardiac Disorder |
3.2% |
| Crohn's Disease |
3.2% |
| Mantle Cell Lymphoma |
3.2% |
| Tuberculosis |
3.2% |
| Adrenal Insufficiency |
2.2% |
| Anorectal Discomfort |
2.2% |
| Colitis Ulcerative |
2.2% |
| Discomfort |
2.2% |
| Erythema |
2.2% |
|
| Pyrexia |
25.6% |
| Drug Ineffective |
17.9% |
| Neutropenia |
5.1% |
| Urinary Incontinence |
5.1% |
| Urticaria |
5.1% |
| Ventricular Fibrillation |
5.1% |
| Anaphylactic Reaction |
2.6% |
| Cerebral Haemorrhage |
2.6% |
| Chest Pain |
2.6% |
| Chorioretinopathy |
2.6% |
| Delirium |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Ductus Arteriosus Premature Closure |
2.6% |
| Dyspnoea |
2.6% |
| Endophthalmitis |
2.6% |
| Hepatic Function Abnormal |
2.6% |
| Hypersensitivity |
2.6% |
| Hypertrophic Cardiomyopathy |
2.6% |
| Lethargy |
2.6% |
| Leukocytosis |
2.6% |
|
| Secondary |
| Burkitt's Lymphoma |
11.3% |
| Ill-defined Disorder |
9.1% |
| Drug Use For Unknown Indication |
8.7% |
| Non-hodgkin's Lymphoma |
7.0% |
| Product Used For Unknown Indication |
7.0% |
| Prostate Cancer |
5.7% |
| Dry Skin |
5.2% |
| Erythema |
5.2% |
| Rash |
5.2% |
| Skin Fissures |
5.2% |
| Acquired Immunodeficiency Syndrome |
4.3% |
| Pain |
4.3% |
| Pruritus |
3.5% |
| Hypertension |
3.0% |
| Post Transplant Lymphoproliferative Disorder |
3.0% |
| Adrenal Disorder |
2.6% |
| Cardiac Disorder |
2.6% |
| Oedema Peripheral |
2.6% |
| Tuberculosis |
2.6% |
| Addison's Disease |
1.7% |
|
| Pyrexia |
12.8% |
| Sepsis |
10.6% |
| Erythema |
8.5% |
| Asthenia |
6.4% |
| Drug Ineffective |
6.4% |
| Glaucoma |
6.4% |
| Spinal Fracture |
6.4% |
| Tremor |
6.4% |
| Addison's Disease |
4.3% |
| Polyneuropathy |
4.3% |
| Therapeutic Response Unexpected |
4.3% |
| Transplant Rejection |
4.3% |
| Weight Increased |
4.3% |
| Cardiac Death |
2.1% |
| Cd4 Lymphocytes Decreased |
2.1% |
| Drug Interaction |
2.1% |
| Hunger |
2.1% |
| Hyperglycaemia |
2.1% |
| Immunosuppression |
2.1% |
| Inflammation |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
14.0% |
| Product Used For Unknown Indication |
9.2% |
| Rheumatoid Arthritis |
8.0% |
| Hypertension |
7.1% |
| Prophylaxis |
7.1% |
| Constipation |
6.0% |
| Pruritus |
5.6% |
| Crohn's Disease |
4.7% |
| Gastroenteritis |
4.4% |
| Infection Prophylaxis |
4.0% |
| Nasopharyngitis |
3.7% |
| Hiv Infection |
3.6% |
| Pain |
3.6% |
| Upper Respiratory Tract Infection |
3.3% |
| Premedication |
3.0% |
| Diarrhoea |
2.9% |
| Eczema |
2.7% |
| Haemorrhoids |
2.6% |
| Hepatitis C |
2.3% |
| Insomnia |
2.2% |
|
| Urinary Retention |
18.2% |
| Urinary Tract Infection |
7.8% |
| Vomiting |
6.5% |
| Weight Decreased |
6.5% |
| Macular Oedema |
5.2% |
| Rash |
5.2% |
| Respiratory Failure |
5.2% |
| Swelling Face |
5.2% |
| Colon Cancer |
3.9% |
| Diarrhoea |
3.9% |
| Gastroenteritis |
3.9% |
| Hypoglycaemia |
3.9% |
| Orthostatic Hypotension |
3.9% |
| Renal Impairment |
3.9% |
| Sepsis |
3.9% |
| Aspergillosis |
2.6% |
| Depression |
2.6% |
| Hypertension |
2.6% |
| Ileostomy |
2.6% |
| Infusion Related Reaction |
2.6% |
|
| Interacting |
| Addison's Disease |
50.0% |
| Smoking Cessation Therapy |
50.0% |
|
|
